Related Experiment Video
Updated: May 25, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
Platelets as Programmable Drug Depots: Toward Predictive and Mechanistic Drug Loading
1Research Center for Translational Medicine, Sirius University of Science and Technology, Sirius 354340, Russia.
Platelet granules can be engineered as programmable drug depots. Rational design strategies, using physicochemical principles and computational modeling, optimize drug loading and release for advanced drug delivery systems.
Area of Science:
- Biomedical Engineering
- Pharmaceutical Science
- Nanotechnology
Background:
- Efficient drug delivery faces challenges with synthetic nanocarriers in biological systems.
- Blood platelets offer potential as biomimetic carriers, but their drug storage capacity is underutilized.
Purpose of the Study:
- To propose platelet granules as programmable drug depots.
- To outline a framework for rational control of drug loading and release.
- To enable model-guided engineering of platelet-based drug delivery platforms.
Main Methods:
- Utilizing physicochemical principles for passive accumulation (ion trapping).
- Leveraging endogenous transport mechanisms for active uptake.
- Applying computational modeling, molecular descriptors, and machine learning for prediction and optimization.
Main Results:
- Demonstrated a conceptual design loop linking prediction and molecular optimization.
- Identified pathways for rational control over drug loading into platelet granules.
- Showcased potential for predicting and enhancing drug compatibility and accumulation efficiency.
Conclusions:
- Platelets can be engineered as programmable drug depots beyond simple biomimetic carriers.
- Rational design strategies can optimize drug loading and release kinetics.
- This approach bridges biological systems with engineering principles for advanced drug delivery.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

